// App-Quantinova.ai

1394 : Epidemiology Of Invasive Aspergillosis (IA) During Induction Therapy In Adults With Acute Lymphoblastic Leukemia (ALL): A Graall-2005 Study

Researchers

Presenter

  • Clara Mariette

Principal Investigators

  • Anne Thiebaut

  • Jean-Yves Cahn

  • Aline Schmidt

  • Herve Dombret

  • Didier Hocquet

  • Agnes Huynh

  • Francoise Isnard

  • Faezeh Legrand

  • Veronique Lheritier

  • Emmanuelle Tavernier

  • Emmanuel Raffoux

  • Norbert Ifrah

Medical Centers

  • Hematology, CHU, Angers, France

  • Angers University Hospital, Angers, France

  • Rheumatology Department, Toulouse University Hospital, Toulouse, France

  • ALFA coordination, Saint-Louis Hospital, Paris, France

  • Hematology, Hospital Saint Antoine, Paris, France,

  • Pediatric Hematology, Institut de Cancerologie de la Loire, Saint Priest En Jarez, France

  • Besancon University Hospital, Infection Control Department, Besancon, France

  • Hematology unit, CHU Nice, Nice, France

  • GRAALL Coordination Center, Centre Hospitalier Lyon Sud, Pierre Benite, France

  • Hematology Department, Grenoble University Hospital, Grenoble, France

  • Hematology department, Saint-Louis Hospital, AP-HP, Paris University, Paris, France

  • Department of Hematology, Grenoble University Hospital, Grenoble, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

  • Hematological malignancies

  • Invasive fungal infection

  • Neutropenia

Biomarkers

  • B-lymphocyte antigen CD20

  • Breakpoint Cluster Region

Drug/Treatment

  • amphotericin b cholesteryl sulfate complex Intravenous

  • MK0991 (IV)

  • Fluconazole

  • Rituximab

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim